Top 50 Medical VC Funds & Investors in Italy (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
10 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $488k–$17M |
|
Italian Angels for Growth
VC Fund
|
8 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$11M |
|
Innogest Capital
VC Fund
|
6 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
Panakes Partners
VC Fund
|
6 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Medical Device | $3.3M–$110M |
|
Invitalia Ventures
VC Fund
|
4 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
LIFTT
VC Fund
|
4 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Vertis
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Series A | Software, Computer, E-Commerce | $823k–$10M |
|
Indaco Venture Partners
VC Fund
|
3 | Italy, Switzerland, United States | Series A, Series B | Biotechnology, Health Care, Life Science | $1.5M–$52M |
|
Equiter
VC Fund
|
2 | Italy | Seed, Series B, Convertible Note | Medical, Health Care, Information Technology | $2.2M–$3.8M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$43M |
|
Principia SGR
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Lumen Ventures
VC Fund
|
2 | Italy | Seed, Series A, Pre-Seed | Medical, InsurTech, Insurance | $1.3M–$14M |
|
Scientifica Venture Capital
VC Fund
|
2 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$1.9M |
|
Lazio Innova
VC Fund
|
2 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Software, Health Care, Artificial Intelligence | $27k–$1.9M |
|
CDP Equity
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | SaaS, Beauty, Events | $2.7M–$4M |
|
Fin Posillipo Spa
VC Fund
|
1 | Italy | Seed | Medical, Wellness, Health Care | |
|
Romed
VC Fund
|
1 | Italy | Medical, Wellness, Health Care | ||
|
Finalca
VC Fund
|
1 | Italy | Seed | Medical, Health Care, Biotechnology | |
|
DSM-Firmenich Venturing
VC Fund
|
1 | United States | Series A | Health Care, Biotechnology, Food and Beverage | |
|
Fondazione Cottino
VC Fund
|
1 | Italy | Seed | Medical, mHealth, Diabetes | |
|
Schia Ventures
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
MVM Life Science Partners
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series C, Series B | Health Care, Biotechnology, Medical | $7M–$40M |
|
CRB Inverbío
VC Fund
|
1 | Spain, Mexico | Series A, Seed | Medical, Health Care, Biotechnology | |
|
RECOMEC
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
MPM Capital
VC Fund
|
1 | United States, Canada, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$116M |
|
Sistema Investimenti
VC Fund
|
1 | Italy | Seed | Mobile, Medical, Health Care | $500k–$2.1M |
|
Metaventures
VC Fund
|
1 | Italy, Brazil, United Kingdom | Gaming, Medical, PC Games | ||
|
RedSeed Ventures
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | Retail, Medical, Big Data | $669k–$1.1M |
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Fondazione Golinelli
VC Fund
|
1 | Italy | Seed, Pre-Seed | FinTech, Financial Services, AgTech | $122k–$467k |
|
Rearden Capital Management LLC
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Embed Capital
VC Fund
|
1 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
Angelini Ventures
VC Fund
|
1 | United States, Italy, Belgium | Series A, Series B, Series C | Health Care, Therapeutics, Biotechnology | |
|
Seroba Life Sciences
VC Fund
|
1 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
Kairos Partners
VC Fund
|
1 | Italy | Seed, Series A | FinTech, Financial Services, Fashion | $2M–$11M |
|
Sviluppo Imprese Centro Italia
VC Fund
|
1 | Italy | Seed, Angel, Pre-Seed | Software, Travel, Medical | |
|
Fincarl
VC Fund
|
1 | Italy | Seed | Medical, Health Care | |
|
50 Partners Health
VC Fund
|
1 | ||||
|
Alecla7
VC Fund
|
1 | Italy | Seed, Pre-Seed, Series A | Advice, Retail, Grocery | |
|
Fountain Healthcare Partners
VC Fund
|
1 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
V-Bio Ventures
VC Fund
|
1 | Belgium, France, United States | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$88M |
|
Launch Tennessee
VC Fund
|
1 | United States, China, Italy | Grant, Seed, Series A | Software, Health Care, Medical | $48k–$4M |
|
GM&C Life Sciences Fund
VC Fund
|
1 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $65k–$4.1M |
|
Claris Ventures
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Therapeutics | $2.2M–$25M |
|
UniCredit
VC Fund
|
1 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt, Seed | Manufacturing, Energy, Renewable Energy | $384k–$1.1B |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $14M–$247M |
|
EISMEA
VC Fund
|
1 | Spain, Switzerland, United Kingdom | Grant, Seed | Biotechnology, Software, Health Care | $55k–$2.7M |
|
VI Partners
VC Fund
|
1 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
|
ArchiMed
VC Fund
|
1 | Italy, France, Canada | Private Equity | Health Care, Pharmaceutical, Biotechnology | |
| Access all 138 VC funds in Italy Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 228
- Round size: Seed $488k–$8.3M; Series A $3.3M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
- Mela Works — Manage your work site with Mela, and generate logbooks and reports with one click. Download Mela now!
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 100
- Round size: Seed $329k–$4.6M; Angel $219k–$1.2M; Series A $2.7M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- Fitprime — Il Partner unico per il Wellbeing Aziendale
- Alomana —
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 40
- Round size: Series A $3.3M–$31M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 69
- Round size: Seed $329k–$4.7M; Series A $2.7M–$21M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Maieutical Labs — I Maieutical Labs sono un insieme di piattaforme ispirate al Mastery Learning, immersive e mobile-oriented, dedicate allo studio nella scuola secondaria
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Computer, E-Commerce
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 62
- Round size: Seed $823k–$3.6M; Series A $1.5M–$10M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Tuidi — Tuidi is a tech startup that develops predictive models of AI, with a particular focus on the food distribution sector. They combine methodical study of data, personalization of business processes and speed of integration for to return an output that is not only accurate but also free from interpretation difficulties so as to increase profits,reduce stock outages and optimize inventories.
- Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
- TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: Italy, Switzerland, United States
Investor stats
- Total investments: 42
- Round size: Series A $1.5M–$31M; Series B $8.8M–$52M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B, Convertible Note
- Geography: Italy
Investor stats
- Total investments: 6
- Round size: Seed $2.2M–$3.8M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
- Medics — 3D anatomical modeling per la pianificazione pre-operatoria e il supporto intra-operatorio delle chirurgie complesse.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 31
- Round size: Series A $2.7M–$43M; Series B $7.9M–$40M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- Industry: Medical, InsurTech, Insurance
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 6
- Round size: Seed $1.3M–$5.3M; Series A $6M–$14M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
- AutoConnexa — Connexa InsTech is a digital and telematics insurance company solution offering unprecedented customer-centricity and flexibility. It was founded in 2021 and its headquarters is located in Bari, Apulia, Italy.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 12
- Round size: Seed $553k–$1.9M; Pre-Seed $209k–$541k
- Lead/follow: 83% lead, 17% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- PlantBit — PlantBit is a producer of sensors and services for smart farming.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
- LayerLogic AB — Reliable and instantaneous bacteria detection
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $186k–$1.9M; Grant $27k–$33k; Pre-Seed $53k–$549k
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Joinrs — Cut the noise. Joinrs uses AI to find the jobs that actually match your skills, experience and preferences. Over 2 million job seekers trust Joinrs.
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
- Ticketoo — Compra e vendi biglietti in modo etico su Ticketoo. La piattaforma sicura per transazioni fan-to-fan. Trova i migliori eventi e assicurati il biglietto per i tuoi spettacoli preferiti.
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: SaaS, Beauty, Events
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$4M; Series A $2.7M–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Neuranix — Neuranix develops, manufactures, and markets innovative devices for the diagnosis of ear diseases in the medical and veterinary fields. They own several patents in the audiological field. They create products based on the analysis of the acoustic characteristics of the eardrum and middle ear measured over a broad spectrum of frequencies. Theysupport the diagnosis and monitor the therapy of middle ear pathologies.
- Rubber Conversion — Rubber Conversion provides recycling, product sustainability, custom packaging, environmental impact analysis, material tracking, and online document management. Their customers contact them through phone, email, and online applications.
Familiy Office of Petrone Group
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Romed is an investment firm.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Finalca is an Investment Company.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
DSM-Firmenich Venturing provides venture capital finance for startup firms.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- one.bio — BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
- Enhanced Medical Nutrition — Enhanced Medical Nutrition builds clinical nutrition products to help patients prepare better and recover faster from surgery.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.
Show more...Investment focus
- Industry: Medical, mHealth, Diabetes
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
Schia Ventures is investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series C, Series B
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 74
- Round size: Series B $7M–$40M; Series C $12M–$39M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $500M in 2022
Portfolio highlights
- Cara Therapeutics — Welcome toTvardi Therapeutics Cara Therapeuticsis nowTvardi Therapeutics Read Press Release
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
- Spherics — Astrodyne TDI is a leading EMI/RFI/EMC and power supplies manufacturer with over 60 years of experience. Request a quote to find a custom solution today.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Mexico
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
RECOMEC operates as a venture capital firm that primarily invests in the healthcare sector.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 224
- Round size: Series A $9M–$84M; Series B $20M–$116M; Series C $12M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $850M in 2021
Portfolio highlights
- Epigenomics — Epigenomics is a molecular diagnostics company focusing on the development and commercialization of in vitro diagnostic tests for cancer. Its cancer diagnostic tests aim at finding cancer at early stages before symptoms occur and are carried out conveniently on body fluids such as blood plasma. These tests potentially address millions ofindividuals in each of the major markets such as the United States, Europe, and Japan and provide product opportunities each with peak sales potentials of several hundred millions of euros for diagnostics companies worldwide. Its lead test development program is in colorectal cancer. Further test are in development for lung and prostate cancer. Each of its products in development addresses either mass markets or high-value niches. While some of them lend themselves to partnering with established diagnostics industry players, others can be commercialized effectively by Epigenomics itself. The concept of its diagnostic tests in development relies on detecting differences in DNA methylation patterns between healthy and sick individuals or between subgroups of patients for disease classification.
- Umoja Biopharma — Pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells.
- Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.
Show more...Investment focus
- Industry: Mobile, Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Seed $500k–$2.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
We invest in the Metaverse
Show more...Investment focus
- Industry: Gaming, Medical, PC Games
- Geography: Italy, Brazil, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- 4MDG — 4MDG focuses on providing various data management services such as registration portal, retail technology and customer registration.
- Dubit — Choose your path in the Metaverse.
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.
Show more...Investment focus
- Industry: Retail, Medical, Big Data
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 5
- Round size: Seed $669k–$1.1M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Dianax — Milan-based Dianax was founded in 2013 starting from a group scientists led by Eugenio Iannone and Maurizio Moroni and by a few angel investors orchestrated by Gabriele Bavagnoli. Dianax mission is to develop and manufacture labs-on-chip aiming to trasform protein-based diagnostics and make it prompt, easy to use, inexpensive and reliableTheDianax novel technology is designed to make precise diagnostic results convenient, easily accessible, and affordable to patients and healthcare professionals, to empower them to effective prevention, ongoing accurate management and timely emergency treatment.The Dianax technology is the first ever application to diagnostics of a combination of microfluidic innovations and electrochemistry detection systems.Dianax was founded by Eugenio Iannone and his partners to pursue technical and market opportunities based on proprietary, independent research.
- Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
- WIB Machines — Smart vending machines and smart lockers manufacturer pioneering smart, web-based retail automation globally. Patented solutions enabling next-gen retail.
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.
Show more...Investment focus
- Industry: FinTech, Financial Services, AgTech
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $122k–$467k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
- EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
- Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
Rearden Capital is a trading and investment firm managing proprietary capital across commodity, currency, fixed income and equity asset classes and related derivative instruments in the global markets.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Angelini Ventures is an investment firm.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Italy, Belgium
Investor stats
- Total investments: 18
- Lead/follow: no public data
Portfolio highlights
- Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
- Avation Medical — 42 million men and women have symptoms of OAB and incontinence. Vivally can help.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $111M in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Novate Medical — NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device thatsimultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.
- INNOVO by Atlantic Therapeutics — INNOVO is a completely non-invasive, clinically proven and long-lasting solution to urinary incontinence and bladder weakness. See results in 4 weeks!
Kairos Partners SGR is a independent Italian asset management company.
Show more...Investment focus
- Industry: FinTech, Financial Services, Fashion
- Stage:Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2M–$11M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
- Hercle — Hercle is a regulated digital asset liquidity provider specializing in OTC trading and market making.
- Underscore District — Underscore District unlocks the potential of Made in Italy fashion brands through the power of technology and data analytics.
Sviluppo Imprese Centro Italia is an independent asset management company founded in Florence in 1998. Active in the Private Equity and Venture Capital sector, it currently manages four closed-end funds for a total value of around 140 million euro and has already carried out numerous operations. in the capital of companies operating in variousindustrial sectors, from the most traditional to high-tech. The mission of SICI is to encourage the development of unlisted SMEs in Central Italy through the contribution of financial resources intended to strengthen their capital and financial structure. SICI intends to represent a Growth Partner for the investee companies and a strategic operator in the creation of value for the territory with an impact on the economic and social fabric in terms of competitiveness of the economic system, employment, entrepreneurial and managerial culture. Business Development Central Italy is an independent Italian managing closed-end funds company. Established in Florence in 1998, SICI has 4 Private Equity and Venture funds under management with a total committed capital of 140m Euros.
Show more...Investment focus
- Industry: Software, Travel, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Cents — Cents is a platform that allows businesses to raise awareness in the market by supporting social and environmental causes.
- Parking My Car — Parking My Car offers transportation services.
- Recuperiamo srl — Recuperiamo srl is a food industry founded to prevent and reduce waste throughout the food chain. They are involved in the food industry through the Regusto brand. They can use geolocation to report on last-minute offers for their dishes.
Fincarl is an investment firm.
Show more...Investment focus
- Industry: Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Lab Evo — Lab Evo is an Italian Digital Healthcare startup that allows customers to manage their health online with direct access to laboratory tests.
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Private investment firm founded by Angelomario Moratti in 2015, which mainly focuses on early-stage VC opportunities
Show more...Investment focus
- Industry: Advice, Retail, Grocery
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Glaut — Glaut is the AI-native platform for market research. Use AI-moderated interviews (AIMI) to collect qualitative insights at scale, with multilingual support, fraud prevention, and real-time analysis.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
- FidoCommercialista — FidoCommercialista is a team of accountants to offer tax support. They use digital technologies to save customers time and money. They provide tax advice for their clients. They respond to customer inquiries by phone, contact form, and email.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 49
- Round size: Series A $6.6M–$44M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 38
- Round size: Seed $3.2M–$50M; Series A $6.6M–$73M; Series B $20M–$88M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $129M in 2021
Portfolio highlights
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
- Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Grant, Seed, Series A
- Geography: United States, China, Italy
Investor stats
- Total investments: 115
- Round size: Seed $517k–$3.8M; Grant $48k–$200k; Series A $400k–$4M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $30M in 2011
Portfolio highlights
- Sage Haven — Sage Haven develops an AI-moderated messaging and calling app designed for children in their early years online. The app issues children a dedicated Sage Haven number and routes messaging and voice calls through its platform while allowing contacts to use services like iMessage or Google Messages. Parents create and verify accounts, approve eachcontact, and supervise conversations from their own phones with alerts, recaps, and safety insights. The service uses automated content moderation to block harmful or inappropriate messages, links, images, and videos before they are sent and to guide children toward safer communication practices. It supports Wi-Fi and cellular use on iOS devices, with tools aimed at reducing exposure to online bullying, spam, and addictive usage patterns. Sage Haven operates as a public benefit corporation balancing commercial activity with a mission to improve children’s mental health and well-being.
- Rebel Audio — Rebel Audio is an agentic podcast platform driven by AI that aims to modernize the production, distribution, and monetization of audio. Rebel Audio is a comprehensive system that simplifies production, publication, analytics, and revenue generation for creators, networks, and media organizations.
- Daily Crunch — Daily Crunch is an offline and online store that offers cherry-berry nuts, cacao sea salt, and sprouted almonds products.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 33
- Round size: Seed $65k–$936k; Series A $1.8M–$4.1M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
- Acea Health — Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .
- Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 11
- Round size: Seed $2.2M–$11M; Series A $6.1M–$25M; Series B $7.9M–$20M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Manufacturing, Energy, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 100
- Round size: Seed $384k–$15M; Post-IPO Debt $40M–$1.1B; Debt Financing $417k–$614M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- FITT — FITT specializes in thermoplastic fluid transfer and management solutions.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
- E4 Computer Engineering — E4 Computer Engineering stands out for its tireless pursuit of the most cutting edge proposals in the IT sector.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 177
- Round size: Series B $14M–$85M; Private Equity $110M–$247M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
Executive Agency for SMEs
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: Spain, Switzerland, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $55k–$2.2M; Grant $55k–$2.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- Cyclomics — Discover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive detection of cancer mutations directly from blood samples, transforming the future of liquid biopsy. Learn more about how Cyclomics is revolutionizing early cancer detection, monitoring, and personalized treatment with cutting-edge, accessible molecular diagnostics.
- Terraplasma — As pioneers in cold plasma science, our team of scientists, engineers, and experts have played a key role in driving research and commercial development. Our groundbreaking work has brought cold plasma technology to companies, public institutions and even private households worldwide.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 110
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Altoida — Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
- SMART VALOR — SMART VALOR is a secure investment platform offering easy buy and sell of cryptocurrencies like Bitcoin, Ethereum, Dash and more. Trade and store digital assets.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
ArchiMed is an independent group with funds provided by the team as well as European and American investors, both institutional and private (including a number of successful healthcare entrepreneurs).
Show more...Investment focus
- Industry: Health Care, Pharmaceutical, Biotechnology
- Stage:Private Equity
- Geography: Italy, France, Canada
Investor stats
- Total investments: 7
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $761M in 2021
Portfolio highlights
- PlasmidFactory — PlasmidFactory is the leading contract manufacturer and service provider for plasmid DNA and minicircle DNA, custom DNA, In-Stock DNA for AAV and clinical application
- Corealis Pharma — Corealis Pharma provides services on a contract basis in the areas of formulation and process development as well as in small-scale clinical trial material manufacturing and the packaging of solid dosage forms to pharmaceutical and biotech companies. Its services include API characterization, salt selection, pre-formulation, formulation and processdevelopment, analytical method development, stability storage, and testing, technical transfer and scale-up, cGMP manufacturing and packaging of phase I and II CTM, and dossier support.
- Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
Medical VC funding in Italy at a glance
Stats across 96 deals from 138 investors.
Access all 138 VC funds in Italy Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 138 VC funds investing in Italy Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!